The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05223192
Collaborator
(none)
118
1
2
23.1
5.1

Study Details

Study Description

Brief Summary

Infants born prematurely at will be asked to participate in this randomized controlled trial at a corrected gestational age of 24-37 weeks. Infants will be randomly selected to each of the two groups: intervention and control. Infants in the treatment group will receive six intervention days over a two-week period, 3 sessions per week. Each intervention day consists of each of the two interventions in a random sequence: no intervention/silence and live ocean disc instrument intervention. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation. Each infant will thus receive control and ocean disc intervention on the same day in the NICU. Interventions will be given in a randomized order (i.e., first ocean disc or first silence, randomized to AM or PM), with observation occurring for 10 minutes before each intervention, 15 minutes during each intervention, and 10 minutes after each per session. There will be 3 sessions per week for a two-week randomized treatment schedule. For each infant, data on total apnea time, mean respiratory rate, heart rate, O2 levels and behavior rating during will be collected. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation and hearing damage. Near-infrared light spectroscopy (NIRS) data on cerebral oxygenation will also be collected. Observations will be recorded on the infant's activity or when change occurs, such as a pacifier falling out. Parents and nurses will be asked to behave as they normally would during routine care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Music Therapy Entrainment with Ocean Disc Intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Participants in this group will receive the ocean disc music therapy entrainment intervention

Behavioral: Music Therapy Entrainment with Ocean Disc Intervention
The studied intervention regards live entrainment with the ocean disc. Entrainment involves the use of an external stimulus, in the case of this study, an ocean disc instrument. Motion of the disc creates sounds in synchrony with the breathing of the infant and then in turn can control and influence the infant's regulation of the breath.

No Intervention: Control group

Participants in this group will not receive any intervention

Outcome Measures

Primary Outcome Measures

  1. Heart Rate [14 days]

  2. Respiratory Rate [14 days]

  3. Oxygen-Saturation Level [14 days]

  4. Weight [14 days]

  5. Cerebral oxygen saturation [14 days]

    Cerebral oxygen saturation measured using NIRS

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Weeks to 37 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Newborns born at 24-37 weeks' gestation at Mount Sinai hospital

  • Newborn is considered appropriate for clinically indicated music therapy

Exclusion Criteria:
  • Infant not expected to survive 24 hours from the time of study entry (To be assessed by a member of the NICU Faculty other than the PI)

  • Infant of uncertain viability (gestation <23 weeks, birth weight <500 grams)

  • Known or suspected genetic disorder (e.g., Trisomy 21)

  • Identified hearing disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Sinai Hospitals New York New York United States 10003

Sponsors and Collaborators

  • Icahn School of Medicine at Mount Sinai

Investigators

  • Study Director: Joanne V Loewy, DA, MT-BC, LCAT, Icahn School of Medicine at Mount Sinai
  • Principal Investigator: Lauren Fagan, MT-BC, LCAT, Mount Sinai Beth Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lauren June Fagan, Music Therapist, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT05223192
Other Study ID Numbers:
  • STUDY-21-01783
First Posted:
Feb 3, 2022
Last Update Posted:
Feb 24, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Lauren June Fagan, Music Therapist, Icahn School of Medicine at Mount Sinai
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2022